Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower
Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower
President-elect Donald Trump picked Robert F. Kennedy Jr., known for his vaccine skepticism, as his nominee Thursday to lead the Department of Health and Human Services.
当选总统特朗普在周四提名以生物-疫苗怀疑闻名的罗伯特·F·肯尼迪作为领导卫生与公众服务部的候选人。
This move, which comes after Kennedy ended his presidential campaign and endorsed Trump, positions the environmental activist to potentially reshape national health policies. The selection has stirred mixed reactions, particularly from public health experts, Politico reports.
这一举动是在肯尼迪结束总统竞选并支持特朗普后作出的,这使得这位环保母基活动家有潜力重新塑造国家健康政策。根据《政治报》的报道,这一选择引发了混合反应,尤其来自公共健康专家。
"For too long, Americans have been crushed by the industrial food complex and drug companies who have engaged in deception, misinformation, and disinformation when it comes to Public Health," Trump said in a tweet announcing the decision.
特朗普在推特上宣布这一决定时说:“太长时间以来,美国人被工业食品复合体和药品公司所压迫,他们在公共健康问题上进行欺骗、错误信息和虚假信息的传播。”
As Benzinga reported earlier this month, Kennedy has a history of spreading falsehoods about vaccines, including that they cause autism, a theory disproven by scientific studies. His selection as the nominee for HHS secretary comes against a backdrop of falling vaccination rates, which coincide with, in one example, 13 measles outbreaks in the U.S. so far this year.
正如本月早些时候《班辛加报》报道的那样,肯尼迪传播关于生物-疫苗的不实信息的历史包括宣称生物-疫苗导致自闭症,这一理论已经被科学研究证明是错误的。他作为卫生与公众服务部部长提名者的选择发生在疫苗接种率下降的背景下,今年美国迄今为止爆发了13起麻疹疫情。
What Happened: Trump's decision is part of a broader promise to "let Kennedy go wild" with health and food policies, aiming to overhaul the HHS. Kennedy has expressed sharp criticisms of several health agencies.
事件概述:特朗普的决定是更广泛承诺的一部分,即“让肯尼迪自由发挥”健康和食品政策,旨在彻底改革卫生与公众服务部。肯尼迪对多个健康机构提出了尖锐的批评。
Kennedy had hinted at the potential role of "health czar" in Trump's administration. If he is confirmed, Kennedy's appointment could influence vaccine policy and the direction of the CDC, FDA, and NIH.
肯尼迪曾暗示他在特朗普政府中可能担任“健康czar”的角色。如果他被确认,肯尼迪的任命可能会影响生物-疫苗政策及美国疾病控制与预防中心、食品药品监督管理局和国立卫生研究院的方向。
Also Read: Will Trump's Election Win Push S&P 500 Even Higher In Final Weeks Of 2024? Over 75% Say...
另请阅读:特朗普的选举胜利会否在2024年最后几周推动标普500进一步上涨?超过75%的人表示...
Kennedy's prospective role has already affected vaccine manufacturer stocks. Major vaccine-related companies saw declines in stock prices on Thursday due to the uncertainty surrounding Kennedy's influence on health policy.
肯尼迪可能的角色已经影响了生物-疫苗制造商的股票。由于围绕肯尼迪对健康政策影响的不确定性,主要生物-疫苗相关公司的股价在周四出现下跌。
Key companies impacted include:
受影响的主要公司包括:
- Moderna Inc. (NASDAQ:MRNA) down 5.62% to $39.77.
- Pfizer Inc. (NYSE:PFE) down 2.62% to $26.02.
- Johnson & Johnson (NYSE:JNJ) down 0.89% to $151.87.
- AstraZeneca plc (NASDAQ:AZN) down 0.38% to $65.04.
- Novavax Inc. (NASDAQ:NVAX) down 7.02% to $7.22.
- 莫德纳公司(纳斯达克:MRNA)下跌5.62%,至39.77美元。
- 辉瑞公司(纽交所:PFE)下跌2.62%,至26.02美元。
- 强生公司(纽交所:JNJ)下跌0.89%,至151.87美元。
- 阿斯利康公司(纳斯达克:AZN)下跌0.38%,至65.04美元。
- 诺瓦瓦克斯公司(纳斯达克:NVAX)下跌7.02%,至7.22美元。
Why It Matters: Kennedy's views on vaccines and health oversight agencies stand in stark contrast to established medical consensus. His appointment could alter public health directives, with some analysts predicting potential shifts in FDA regulatory independence and vaccine guidelines.
重要性:肯尼迪对疫苗和健康监管机构的看法与既定的医疗共识形成鲜明对比。他的任命可能会改变公共卫生指令,一些分析师预测FDA监管独立性和疫苗指南可能会发生变化。
The impact may extend beyond policy, shaping public trust in health systems amid ongoing debates over vaccine safety.
影响可能超越政策,在关于疫苗安全性的持续辩论中塑造公众对健康系统的信任。
Kennedy, while indicating he has no plans to "take away anybody's vaccines," continues to be a polarizing figure. Vaccine-related stocks may experience ongoing volatility as the Trump administration finalizes its health policy agenda.
肯尼迪虽然表示他没有计划 "拿走任何人的生物-疫苗",但他仍然是一个具有分化性的人物。在特朗普行政部门完善其医疗政策议程的过程中,与生物-疫苗相关的股票可能会持续经历波动。
- Trump Plans To Erase EV Tax Credit: Tesla Analyst Says It's 'Net Bullish,' Calls Sell-Off 'Wrong Knee-Jerk Reaction'
- 特朗普计划取消电动车税收抵免:特斯拉分析师表示这"整体看好",并称抛售是"错误的本能反应"
Photo: Shutterstock.
照片:shutterstock。